Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Sequencing of Altica lythri genome

PROVIDER: PRJNA947484 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23937168_1.fastq.gz	Fastqsanger.gz
	SRR23937169_1.fastq.gz	Fastqsanger.gz
	SRR23937170_1.fastq.gz	Fastqsanger.gz
	SRR23937170_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

icAltLyth

Project description:Altica lythri

| PRJEB72117 | ENA

Altica lythri

Project description:Altica lythri overview

| PRJNA1100686 | ENA

icAltLyth1

Project description:Altica lythri genome assembly, icAltLyth1

| PRJEB74861 | ENA

Altica lythri genome and transcriptomes to identify sex and haplotype specific differences

Project description:Altica lythri sex specific markers

| PRJEB50615 | ENA

icAltLyth1 alternate haplotype

Project description:Altica lythri genome assembly, icAltLyth1, alternate haplotype

| PRJEB74862 | ENA

icAltLyth

Project description:Altica lythri, genomic and transcriptomic data

| PRJEB72116 | ENA

Project description:Identification of sex-linked marker of Altica lythri

| PRJNA1136704 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Gut bacteria

Project description:Gut bacteria of three Altica species Genome sequencing and assembly

| PRJNA592411 | ENA

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

Project description:The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers with specimens that they can use to develop comprehensive catalogs of genomic information on at least 50 types of human cancer. The study will create a resource available to the worldwide research community that could be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. This study will be a competitive enrollment study conducted at multiple institutions.

| 2140168 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data